Us Food And Drug Administration - Toxicology

Relevant Publications

Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.

Issue Release: 2024

Whiteness and greenness assessments of a sensitive HPLC method with fluorimetric detection for dapagliflozin quantitation in human plasma: Application to a healthy human volunteer.

Issue Release: 2024

Determination of procoagulant activity in human normal immunoglobulin preparations for therapeutic use by FXIa chromogenic assay: Evaluation of test kit sensitivity, reference standard performance and product formulation effects on the FXIa assay.

Issue Release: 2024

Drug-coated balloons for coronary artery disease: An updated review with future perspectives.

Issue Release: 2024

A CD36-dependent non-canonical lipid metabolism program promotes immune escape and resistance to hypomethylating agent therapy in AML.

Issue Release: 2024

Overdosage Section in US and EU Labeling.

Issue Release: 2024

Investigation into the genotoxic impurity, 1-methyl-4-nitrosopiperazine, in rifampicin.

Issue Release: 2024

Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials.

Issue Release: 2024

Pathology of acute sub-lethal or near-lethal irradiation of nonhuman primates prophylaxed with the nutraceutical, gamma tocotrienol.

Issue Release: 2024

Pediatric Device Clinical Trials Activity: 1999-2022.

Issue Release: 2024

Momelotinib for the treatment of myelofibrosis.

Issue Release: 2024

Bispecific Antibody Use in Patients With Lymphoma and Multiple Myeloma.

Issue Release: 2024

One Health Landscape of Antimicrobial Resistance in Bacteria Isolated from Virginia between 2007-2021.

Issue Release: 2024

New and Emerging Drug and Gene Therapies for Friedreich Ataxia.

Issue Release: 2024

FDA-approved disulfiram inhibits the NLRP3 inflammasome by regulating NLRP3 palmitoylation.

Issue Release: 2024

Guselkumab - In Psoriasis and Beyond.

Issue Release: 2024

Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States.

Issue Release: 2024

Model-based comparisons of post-treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European Union.

Issue Release: 2024

An investigation of broad-spectrum antibiotic-induced liver injury based on the FDA Adverse Event Reporting System and retrospective observational study.

Issue Release: 2024

Piplartine attenuates aminoglycoside-induced TRPV1 activity and protects from hearing loss in mice.

Issue Release: 2024

What Are the Safety Benefits of Using Robotics?

Are There Protective Measures Against M Phase Disruption?

Why Are Cystine Crystals Relevant in Toxicology?

What are Virulence Factors?

What Makes Fructose in SSBs Potentially Harmful?

What are the Treatment Options for Ethanol Poisoning?

Are there any natural substances with antifungal activity against Candida albicans?

How Does the Body Detoxify the Digestive System?

What is the Role of Cytochrome P450?

What Role Do Caspases Play?

Partnered Content Networks

Relevant Topics